Pharmaceutical News and Articles

Triple Semicircular Canal Plugging Effective for Vertigo Control in Meniere Disease

Triple semicircular canal plugging (TSCP) is effective for vertigo control but is associated with a risk for hearing loss in patients with Meniere disease (MD),

Propranolol May Reduce Overall Stroke Risk in Women With Migraine

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke, accord

Bird Flu Studies Delayed as White House Halts CDC Reports

As a bird flu outbreak escalates across the U.S., the Trump administration has paused the release of key public health studies, stalling research that could pro

Intermittent Fasting Aids Some Outcomes for Postmenopausal Women With RA

Intermittent fasting may benefit antioxidant and inflammatory markers in postmenopausal women with rheumatoid arthritis, according to a study published online J

FDA Approves Journavx, First New Non-Opioid Pain Pill in Decades

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin a

Prehospital Blood Test Can Rapidly Differentiate Stroke Types

Prehospital measurement of glial fibrillary acidic protein (GFAP) can rapidly differentiate intracerebral hemorrhage (ICH) from ischemic stroke (IS) and stroke

Daily, Long-Term Aspirin Use Reduces Colorectal Cancer Recurrence

Adjuvant treatment with 160 mg aspirin daily for three years cuts recurrence rates in patients with colorectal cancer with somatic alterations in the phosphoino

FDA Approves Datroway for HR-Positive, HER2-Negative Breast Cancer

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with unresectable or metastatic, hormone receptor (

Temperature Exposure Linked to Adolescent Psychiatric Symptoms

Exposure to cold in the Netherlands and to heat in Spain appears to be associated with more psychiatric symptoms among adolescents, according to a study publish

FDA Approves Symbravo (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults